Miriam A. Schiele
University of Würzburg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Miriam A. Schiele.
Translational Psychiatry | 2016
C. Ziegler; Jan Richter; M Mahr; A Gajewska; Miriam A. Schiele; A Gehrmann; Brigitte Schmidt; Klaus-Peter Lesch; Thomas Lang; Sylvia Helbig-Lang; Paul Pauli; Tilo Kircher; Andreas Reif; Winfried Rief; Anna N. Vossbeck-Elsebusch; Volker Arolt; Hans-Ulrich Wittchen; Alfons O. Hamm; J. Deckert; Katharina Domschke
Epigenetic signatures such as methylation of the monoamine oxidase A (MAOA) gene have been found to be altered in panic disorder (PD). Hypothesizing temporal plasticity of epigenetic processes as a mechanism of successful fear extinction, the present psychotherapy-epigenetic study for we believe the first time investigated MAOA methylation changes during the course of exposure-based cognitive behavioral therapy (CBT) in PD. MAOA methylation was compared between N=28 female Caucasian PD patients (discovery sample) and N=28 age- and sex-matched healthy controls via direct sequencing of sodium bisulfite-treated DNA extracted from blood cells. MAOA methylation was furthermore analyzed at baseline (T0) and after a 6-week CBT (T1) in the discovery sample parallelized by a waiting time in healthy controls, as well as in an independent sample of female PD patients (N=20). Patients exhibited lower MAOA methylation than healthy controls (P<0.001), and baseline PD severity correlated negatively with MAOA methylation (P=0.01). In the discovery sample, MAOA methylation increased up to the level of healthy controls along with CBT response (number of panic attacks; T0–T1: +3.37±2.17%), while non-responders further decreased in methylation (−2.00±1.28%; P=0.001). In the replication sample, increases in MAOA methylation correlated with agoraphobic symptom reduction after CBT (P=0.02–0.03). The present results support previous evidence for MAOA hypomethylation as a PD risk marker and suggest reversibility of MAOA hypomethylation as a potential epigenetic correlate of response to CBT. The emerging notion of epigenetic signatures as a mechanism of action of psychotherapeutic interventions may promote epigenetic patterns as biomarkers of lasting extinction effects.
Social Cognitive and Affective Neuroscience | 2016
Manuel Kuhn; Robert Scharfenort; Dirk Schümann; Miriam A. Schiele; Anna Luisa Münsterkötter; Jürgen Deckert; Katharina Domschke; Jan Haaker; Raffael Kalisch; Paul Pauli; Andreas Reif; Marcel Romanos; Peter Zwanzger; Tina B. Lonsdorf
Traditionally, adversity was defined as the accumulation of environmental events (allostatic load). Recently however, a mismatch between the early and the later (adult) environment (mismatch) has been hypothesized to be critical for disease development, a hypothesis that has not yet been tested explicitly in humans. We explored the impact of timing of life adversity (childhood and past year) on anxiety and depression levels (N = 833) and brain morphology (N = 129). Both remote (childhood) and proximal (recent) adversities were differentially mirrored in morphometric changes in areas critically involved in emotional processing (i.e. amygdala/hippocampus, dorsal anterior cingulate cortex, respectively). The effect of adversity on affect acted in an additive way with no evidence for interactions (mismatch). Structural equation modeling demonstrated a direct effect of adversity on morphometric estimates and anxiety/depression without evidence of brain morphology functioning as a mediator. Our results highlight that adversity manifests as pronounced changes in brain morphometric and affective temperament even though these seem to represent distinct mechanistic pathways. A major goal of future studies should be to define critical time periods for the impact of adversity and strategies for intervening to prevent or reverse the effects of adverse childhood life experiences.
Journal of Neural Transmission | 2016
Miriam A. Schiele; C. Ziegler; Karoline Holitschke; C. Schartner; Brigitte Schmidt; Heike Weber; Andreas Reif; Marcel Romanos; Paul Pauli; Peter Zwanzger; Jürgen Deckert; Katharina Domschke
Environmental vulnerability factors such as adverse childhood experiences in interaction with genetic risk variants, e.g., the serotonin transporter gene linked polymorphic region (5-HTTLPR), are assumed to play a role in the development of anxiety and affective disorders. However, positive influences such as general self-efficacy (GSE) may exert a compensatory effect on genetic disposition, environmental adversity, and anxiety traits. We, thus, assessed childhood trauma (Childhood Trauma Questionnaire, CTQ) and GSE in 678 adults genotyped for 5-HTTLPR/rs25531 and their interaction on agoraphobic cognitions (Agoraphobic Cognitions Questionnaire, ACQ), social anxiety (Liebowitz Social Anxiety Scale, LSAS), and trait anxiety (State-Trait Anxiety Inventory, STAI-T). The relationship between anxiety traits and childhood trauma was moderated by self-efficacy in 5-HTTLPR/rs25531 LALA genotype carriers: LALA probands maltreated as children showed high anxiety scores when self-efficacy was low, but low anxiety scores in the presence of high self-efficacy despite childhood maltreatment. Our results extend previous findings regarding anxiety-related traits showing an interactive relationship between 5-HTT genotype and adverse childhood experiences by suggesting coping-related measures to function as an additional dimension buffering the effects of a gene-environment risk constellation. Given that anxiety disorders manifest already early in childhood, this insight could contribute to the improvement of psychotherapeutic interventions by including measures strengthening self-efficacy and inform early targeted preventive interventions in at-risk populations, particularly within the crucial time window of childhood and adolescence.
Developmental Psychobiology | 2016
Miriam A. Schiele; Julia Reinhard; Andreas Reif; Katharina Domschke; Marcel Romanos; Jürgen Deckert; Paul Pauli
ABSTRACT Most research on human fear conditioning and its generalization has focused on adults whereas only little is known about these processes in children. Direct comparisons between child and adult populations are needed to determine developmental risk markers of fear and anxiety. We compared 267 children and 285 adults in a differential fear conditioning paradigm and generalization test. Skin conductance responses (SCR) and ratings of valence and arousal were obtained to indicate fear learning. Both groups displayed robust and similar differential conditioning on subjective and physiological levels. However, children showed heightened fear generalization compared to adults as indexed by higher arousal ratings and SCR to the generalization stimuli. Results indicate overgeneralization of conditioned fear as a developmental correlate of fear learning. The developmental change from a shallow to a steeper generalization gradient is likely related to the maturation of brain structures that modulate efficient discrimination between danger and (ambiguous) safety cues.
BMC Psychiatry | 2014
Julia Volkert; Kathrin Zierhut; Miriam A. Schiele; Martina Wenzel; Juliane Kopf; Sarah Kittel-Schneider; Andreas Reif
BackgroundA large number of patients with bipolar disorder (BD) can be characterized by predominant polarity (PP), which has important implications for relapse prevention. Recently, Popovic et al. (EUR NEUROPSYCHOPHARM 22(5): 339-346, 2012) proposed the Polarity Index (PI) as a helpful tool in the maintenance treatment of BD. As a numeric expression, it reflects the efficacy of drugs used in treatment of BD. In the present retrospective study, we aimed to validate this Index in a large and well characterized German bipolar sample.MethodsWe investigated 336 bipolar patients (BP) according to their PP and calculated the PI for each patient in order to prove if maintenance treatment differs according to their PP. Furthermore, we analysed whether PP is associated with demographic and clinical characteristics of BP.ResultsIn our sample, 63.9% of patients fulfilled criteria of PP: 169 patients were classified as depressive predominant polarity (DPP), 46 patients as manic predominant polarity (MPP). The two groups differed significantly in their drug regime: Patients with DPP were more often medicated with lamotrigine and antidepressants, patients with MPP were more often treated with lithium, valproate, carbamazepine and first generation antipsychotics. However, patients with DPP and MPP did not differ significantly with respect to the PI, although they received evidence-based and guideline-driven treatment.ConclusionThe reason for this negative finding might well be that for several drugs, which were used frequently, no PI value is available. Nevertheless we suggest PP as an important concept in the planning of BD maintenance treatment.
Zeitschrift Fur Psychologie-journal of Psychology | 2017
Christian R. Baumann; Miriam A. Schiele; Martin J. Herrmann; Tina B. Lonsdorf; Peter Zwanzger; Katharina Domschke; Andreas Reif; Jürgen Deckert; Paul Pauli
Conditioning and generalization of fear are assumed to play central roles in the pathogenesis of anxiety disorders. Here we investigate the influence of a psychometric anxiety-specific factor on these two processes, thus try to identify a potential risk factor for the development of anxiety disorders. To this end, 126 healthy participants were examined with questionnaires assessing symptoms of anxiety and depression and with a fear conditioning and generalization paradigm. A principal component analysis of the questionnaire data identified two factors representing the constructs anxiety and depression. Variations in fear conditioning and fear generalization were solely associated with the anxiety factor characterized by anxiety sensitivity and agoraphobic cognitions; high-anxious individuals exhibited stronger fear responses (arousal) during conditioning and stronger generalization effects for valence and UCS-expectancy ratings. Thus, the revealed psychometric factor “anxiety” was associated with enhanced fear generalization, an assumed risk factor for anxiety disorders. These results ask for replication with a longitudinal design allowing to examine their predictive validity.
European Neuropsychopharmacology | 2015
Julia Volkert; Juliane Kopf; J. Kazmaier; F. Glaser; Kathrin Zierhut; Miriam A. Schiele; Sarah Kittel-Schneider; Andreas Reif
European Archives of Psychiatry and Clinical Neuroscience | 2016
Julia Volkert; Miriam A. Schiele; Julia Kazmaier; Friederike Glaser; K. C. Zierhut; Juliane Kopf; Sarah Kittel-Schneider; Andreas Reif
European Archives of Psychiatry and Clinical Neuroscience | 2018
Susanne Neufang; Maximilian J. Geiger; György A. Homola; Marina Mahr; Miriam A. Schiele; Andrea Gehrmann; Brigitte Schmidt; Agnieszka Gajewska; Johannes Nowak; Eva Meisenzahl-Lechner; Mirko Pham; Marcel Romanos; Atae Akhrif; Katharina Domschke
European Neuropsychopharmacology | 2016
C. Ziegler; J. Richter; M. Mahr; A. Gajewska; Miriam A. Schiele; Thomas Lang; Paul Pauli; Andreas Reif; W. Rief; Tilo Kircher; Volker Arolt; Alfons O. Hamm; J. Deckert; Katharina Domschke